Noemí Dorival-García
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Noemí Dorival-García has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Zafra Gómez
José Mataix Verdú" Institute of Nutrition and Food Technology (INYTA), Biomedical Research Centre (CIBM), University of Granada, Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Department of Analytical Chemistry, University of Granada, Granada, Spain
14 shared publications A. Navalón
Research Group of Analytical Chemistry and Life Sciences, Department of Analytical Chemistry, Campus of Fuentenueva, University of Granada, E-18071 Granada, Spain
9 shared publications- Jonathan Bones
National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, Co., Dublin A94 X099, Ireland
7 shared publications - Jose Luis Vílchez
Research Group of Analytical Chemistry and Life Sciences, Department of Analytical Chemistry, Faculty of Sciences, University of Granada, Avda. Fuentenueva s/n, 18071 Granada, Spain
7 shared publications F.J. Camino-Sánchez
Research Group of Analytical Chemistry and Life Sciences, Department of Analytical Chemistry, Campus of Fuentenueva, University of Granada, E-18071 Granada, Spain
3 shared publications- Oscar Ballesteros
Research Group of Analytical Chemistry and Life Sciences, Department of Analytical Chemistry, University of Granada, Campus of Fuentenueva, E-18071 Granada, Spain
3 shared publications
Latest Publications
- Open Access
- 24 March 2026
- Published by Springer Nature in Pharmaceutical Research
- Vol. 43 (4) , 1271-1289
Investigation into Clearance of Organic Compounds from Biomanufacturing Process Streams during Ultrafiltration/Diafiltration
Objective: Ultrafiltration and diafiltration (UF/DF) operations have been demonstrated to clear leachables from drug substance, however there is limited data available. Consequently, comprehensive and systematic characterization of leachables clearance during UF/DF is required and essential. Methods: To achieve this, the reduction capacity for 28 selected organic compounds spiked into 3 different proteins during UF/DF processes was investigated using liquid chromatography high-resolution mass spectrometry. Selection of compounds was based on their presence in representative biomanufacturing processes. Results: Most compounds (24) showed clearance over 98% across the process for the 3 protein materials. The specific protein characteristics and process parameters for each protein had a minimal impact on clearance, with sieving coefficients essentially the same for each one of the 3 protein processes. The sieving coefficient is a parameter that characterizes clearance of compounds during UF/DF. Physicochemical properties of the compounds under study significantly influenced their clearance, with the octanol–water coefficient (Log P) being the most crucial factor. Compounds with Log P < 4 had sieving coefficients close to ideal clearance, and compounds with Log P > 7 showed lower but still significant clearance (> 93%). Other important parameters were established to be molecular weight, polarizability and solvent accessible surface area. Modelling tools based on Orthogonal Partial Least Squares (OPLS) regression were created to predict sieving coefficients. Conclusions: The present work has created a strong background to describe the ability of UF/DF to remove potential organic leachables. Application of these modelling approaches becomes critical to support product safety assessments. Demonstration of significant removal along UF/DF operations confirms risk reduction of leachables coming mostly from upstream stages. Graphical
- 24 March 2026
- Published by Springer Nature in Pharmaceutical Research
- Vol. 43 (4) , 1271-1289
Open AccessInvestigation into Clearance of Organic Compounds from Biomanufacturing Process Streams during Ultrafiltration/Diafiltration
Objective: Ultrafiltration and diafiltration (UF/DF) operations have been demonstrated to clear leachables from drug substance, however there is limited data available. Consequently, comprehensive and systematic characterization of leachables clearance during UF/DF is required and essential. Methods: To achieve this, the reduction capacity for 28 selected organic compounds spiked into 3 different proteins during UF/DF processes was investigated using liquid chromatography high-resolution mass spectrometry. Selection of compounds was based on their presence in representative biomanufacturing processes. Results: Most compounds (24) showed clearance over 98% across the process for the 3 protein materials. The specific protein characteristics and process parameters for each protein had a minimal impact on clearance, with sieving coefficients essentially the same for each one of the 3 protein processes. The sieving coefficient is a parameter that characterizes clearance of compounds during UF/DF. Physicochemical properties of the compounds under study significantly influenced their clearance, with the octanol–water coefficient (Log P) being the most crucial factor. Compounds with Log P < 4 had sieving coefficients close to ideal clearance, and compounds with Log P > 7 showed lower but still significant clearance (> 93%). Other important parameters were established to be molecular weight, polarizability and solvent accessible surface area. Modelling tools based on Orthogonal Partial Least Squares (OPLS) regression were created to predict sieving coefficients. Conclusions: The present work has created a strong background to describe the ability of UF/DF to remove potential organic leachables. Application of these modelling approaches becomes critical to support product safety assessments. Demonstration of significant removal along UF/DF operations confirms risk reduction of leachables coming mostly from upstream stages. Graphical
- 21 December 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 690, 126522
Assessing effects of leachables in single-use systems used in cell therapy manufacture
- 21 December 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 690, 126522
Assessing effects of leachables in single-use systems used in cell therapy manufacture
- Open Access
- 24 September 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Investigation into Clearance of Organic Compounds from Biomanufacturing Process Streams during Ultrafiltration/Diafiltration
Ultrafiltration and diafiltration (UF/DF) operations have been demonstrated to clear leachables from the drug substance, however there is limited data available. Hence, it is beneficial to characterize leachables removal during UF/DF. In this work, the reduction capacity for 28 selected organic compounds spiked into 3 different proteins during UF/DF processes was investigated using liquid chromatography high resolution mass spectrometry. Most compounds (24) showed clearance over 98% across the process for the 3 protein materials. The specific protein characteristics and process parameters for each protein had a minimal impact on clearance, with sieving coefficients essentially the same for each of the 3 protein processes. Physicochemical properties of the studied compounds had a decisive impact on clearance with the octanol-water coefficient (Log P) being most important. Compounds with Log P 7 showed lower but still significant clearance (> 93%). Other influential parameters on clearance were identified to be polarizability, solvent accessible surface area and molecular weight. Orthogonal Partial Least Square (OPLS) regression models were developed and validated using the sieving coefficient to characterize and predict clearance behaviour of organic compounds during UF/DF. Results from this study lay a solid foundation for the understanding and prediction of UF/DF capacity to remove potential organic leachables. Leachables clearance modelling represents an impactful tool which may be utilized to support product safety assessments. Data presented herein demonstrate that UF/DF provides a significant leachables risk reduction with respect to unit operations upstream of UF/DF.
- 24 September 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessInvestigation into Clearance of Organic Compounds from Biomanufacturing Process Streams during Ultrafiltration/Diafiltration
Ultrafiltration and diafiltration (UF/DF) operations have been demonstrated to clear leachables from the drug substance, however there is limited data available. Hence, it is beneficial to characterize leachables removal during UF/DF. In this work, the reduction capacity for 28 selected organic compounds spiked into 3 different proteins during UF/DF processes was investigated using liquid chromatography high resolution mass spectrometry. Most compounds (24) showed clearance over 98% across the process for the 3 protein materials. The specific protein characteristics and process parameters for each protein had a minimal impact on clearance, with sieving coefficients essentially the same for each of the 3 protein processes. Physicochemical properties of the studied compounds had a decisive impact on clearance with the octanol-water coefficient (Log P) being most important. Compounds with Log P 7 showed lower but still significant clearance (> 93%). Other influential parameters on clearance were identified to be polarizability, solvent accessible surface area and molecular weight. Orthogonal Partial Least Square (OPLS) regression models were developed and validated using the sieving coefficient to characterize and predict clearance behaviour of organic compounds during UF/DF. Results from this study lay a solid foundation for the understanding and prediction of UF/DF capacity to remove potential organic leachables. Leachables clearance modelling represents an impactful tool which may be utilized to support product safety assessments. Data presented herein demonstrate that UF/DF provides a significant leachables risk reduction with respect to unit operations upstream of UF/DF.
- Open Access
- 24 September 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Assessing Effects of Leachables in Single-Use Systems used in Cell Therapy Manufacture
Cell therapies (CT) have demonstrated life-changing benefits and curative options to patients with unmet medical needs. Recent commercial successes have strengthened support for the industry; strong clinical responses are propelling additional CT products toward commercialisation. However, manufacturing of CT products continues to create challenges. Extractables and leachables (E&L) are a significant concern for the CT industry, which relies exclusively on single-use systems (SUSs). Investigation of the impact of SUS materials that encounter the cell-based product is a new field and the generation of more information is critical. Here, a proof-of-principle study is presented, demonstrating evidence of effects of leachates on T cells. Jurkat cells, a prototypical T cell line, were cultivated in media previously incubated in single-used bags (SUBs) utilised during incubation/expansion stages. Leachables present in the media were identified by high resolution mass spectrometry (HRAM). The physiological condition of T-cells was assessed using biological assays. Media components and metabolites were analysed over time using a direct infusion-mass spectrometry (DI-MS) method. Media containing leachables resulted in cell growth inhibition and early onset of the apoptosis/necrosis pathways. Changes in membrane mitochondria potential suggested that leachables are cytotoxic via ΔΨm depolarisation, involving the intrinsic apoptotic pathway in the initiation of cell death. Key metabolic pathways were also significantly affected, producing accumulation of toxic metabolites and degradation of nucleic acids and lipids.
- 24 September 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessAssessing Effects of Leachables in Single-Use Systems used in Cell Therapy Manufacture
Cell therapies (CT) have demonstrated life-changing benefits and curative options to patients with unmet medical needs. Recent commercial successes have strengthened support for the industry; strong clinical responses are propelling additional CT products toward commercialisation. However, manufacturing of CT products continues to create challenges. Extractables and leachables (E&L) are a significant concern for the CT industry, which relies exclusively on single-use systems (SUSs). Investigation of the impact of SUS materials that encounter the cell-based product is a new field and the generation of more information is critical. Here, a proof-of-principle study is presented, demonstrating evidence of effects of leachates on T cells. Jurkat cells, a prototypical T cell line, were cultivated in media previously incubated in single-used bags (SUBs) utilised during incubation/expansion stages. Leachables present in the media were identified by high resolution mass spectrometry (HRAM). The physiological condition of T-cells was assessed using biological assays. Media components and metabolites were analysed over time using a direct infusion-mass spectrometry (DI-MS) method. Media containing leachables resulted in cell growth inhibition and early onset of the apoptosis/necrosis pathways. Changes in membrane mitochondria potential suggested that leachables are cytotoxic via ΔΨm depolarisation, involving the intrinsic apoptotic pathway in the initiation of cell death. Key metabolic pathways were also significantly affected, producing accumulation of toxic metabolites and degradation of nucleic acids and lipids.
- 1 September 2017
- Published by Elsevier in Journal of Chromatography A
- Vol. 1513, 69-77
Evaluation of solvent systems for optimized extractables studies of single use bioprocessing solutions
- 1 September 2017
- Published by Elsevier in Journal of Chromatography A
- Vol. 1513, 69-77
Evaluation of solvent systems for optimized extractables studies of single use bioprocessing solutions
- 1 August 2017
- Published by Elsevier in Journal of Chromatography A
- Vol. 1512, 51-60
Monitoring leachables from single-use bioreactor bags for mammalian cell culture by dispersive liquid-liquid microextraction followed by ultra high performance liquid chromatography quadrupole time of flight mass spectrometry
- 1 August 2017
- Published by Elsevier in Journal of Chromatography A
- Vol. 1512, 51-60
Monitoring leachables from single-use bioreactor bags for mammalian cell culture by dispersive liquid-liquid microextraction followed by ultra high performance liquid chromatography quadrupole time of flight mass spectrometry
- 1 August 2017
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 142, 337-342
Non-volatile extractable analysis of prefilled syringes for parenteral administration of drug products
- 1 August 2017
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 142, 337-342
Non-volatile extractable analysis of prefilled syringes for parenteral administration of drug products
- 1 February 2016
- Published by Elsevier in Food Control
- Vol. 60, 382-393
Simultaneous determination of quinolone and β-lactam residues in raw cow milk samples using ultrasound-assisted extraction and dispersive-SPE prior to UHPLC−MS/MS analysis
- 1 February 2016
- Published by Elsevier in Food Control
- Vol. 60, 382-393
Simultaneous determination of quinolone and β-lactam residues in raw cow milk samples using ultrasound-assisted extraction and dispersive-SPE prior to UHPLC−MS/MS analysis